Hydroxy-PEG10-Boc |
| Catalog No.GC66157 |
L'hydroxy-PEG10-Boc est extrait du brevet CN108707228 (exemple 0024). L'hydroxy-PEG10-Boc est un lieur ADC non clivable utilisé dans la synthèse de conjugués anticorps-médicament (ADC). L'hydroxy-PEG10-Boc peut être conjugué au paclitaxel (HY-B0015) ou au docétaxel (HY-B0011).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 778596-26-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Hydroxy-PEG10-Boc is extacted from patent CN108707228 (example 0024)[1]. Hydroxy-PEG10-Boc is a uncleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). Hydroxy-PEG10-Boc can be conjugated to Paclitaxel (HY-B0015) or docetaxel (HY-B0011)[2].
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *